Health Innovation Manchester

Size: px
Start display at page:

Download "Health Innovation Manchester"

Transcription

1 Health Innovation Manchester Accelerating innovation Discover Develop Deploy

2 Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing

3 Foreword Like all cities and countries, Greater Manchester is facing significant public health challenges. This is against a backdrop of rising health and social care costs. At the same time, the challenges and barriers to introducing innovation into health and social care services at pace are global issues. Empowered by devolution, Greater Manchester is uniquely placed to tackle both of these challenges. With a single accountable body responsible for the city region s annual 6 billion health and social care budget, for the first time, Greater Manchester can adopt a system-wide view of the most pressing health and social care needs, agreeing shared priorities, and streamlining processes to enable faster decision-making. An accompanying system-wide approach to innovation is also critical. Health Innovation Manchester is the city region s response. We have established an academic health science system that leverages the city region s entire spectrum of exceptional clinical, academic and public assets, alongside industry innovators, to inject proven innovation into population health, social care, and acute services. Being at the heart of this unique and cohesive system ensures we have an in depth understanding and clear view of the needs of citizens, patients, providers and commissioners. We have listened closely to the challenges and frustrations faced by industry, such as fragmented and slow decision-making, lengthy and uncertain routes to adoption, and structures that do not assist collaboration and coordination. Health Innovation Manchester provides a simplified landscape for researchers and industry innovators. This includes a single gateway into the system, a single innovation pathway, and an enhanced level of assurance in terms of adoption following proof of concept. This is also supported by our emerging world class informatics infrastructure and active development of assets that attract the best industry innovators from across the world - positioning Greater Manchester as the destination of choice for life sciences. Rowena Burns Executive Chair Health Innovation Manchester

4 of The devolution opportunity Greater Manchester is the only city region in the country with control of its combined health and social care budgets - a sum of more than 6 billion annually. A single locally accountable body, Greater Manchester Health and Social Care Partnership, now controls policy and expenditure across all NHS, population health and social care provision for its 2.8m citizens. System-wide innovation that keeps people well, reduces pressure on health and care providers, supports economic growth, and improves health outcomes for citizens and patients. This creates a unique and exciting opportunity to take a systemwide view of the region s most pressing health needs; joining up the work of all health and social care commissioners and providers to meet these needs in the most efficient and cost-effective way. It has also enabled streamlined governance arrangements with joint provider and commissioner priority-setting and decisionmaking at system level: creating the perfect climate for the rapid adoption of proven innovation accross the entire health and care spectrum.

5 of About Health Innovation Manchester Health Innovation Manchester is an Academic Health Science System (AHSS) established to drive proven innovation into health and social care services at pace. Leveraging the exceptional academic and clinical assets of the city region, we bring together basic research, translational research, clinical demand, and industry know-how and investment under a single umbrella; focused wholly on the needs of a population of 2.8m people. Our role is to seek out and bring forward a constant flow of (industry led) innovations, accelerating them through the evaluation process and supporting them through our devolved decision-making structures so they are accepted at pace system-wide. Operating within a devolved health and social care system enables us to create a unique infrastructure and environment for industry innovators to flourish - with a single gateway and innovation pathway, world-class informatics infrastructure, clear view of system needs, and processes that enable speedier decision-making and more certain routes to adoption. A reputation for clinical and translational research aligned to strengths in clinical trials and ground-breaking work in real-world drug trials. Excellence in experimental medicine and biomedical research including major infrastructure for stratified medicine, proteomics, biomarkers, molecular pathology and cancer research. Internationally recognised strength in health informatics, the Farr Institute and NorthWest EHealth. New multi-site Biomedical Research Centre (BRC), harnessing world-class expertise, especially in the field of precision medicine. Academic excellence in the fields of social care and training of allied health professionals. Leading clinical assets and high performing NHS Trust hospitals including The Christie which is globally respected for its work in cancer treatment, and Salford Royal, home to the most mature electronic patient record system in the UK. About Health Innovation Manchester

6 Over the next five years, the region faces significant public health challenges and currently has patient outcomes below national averages against a range of disease and mortality figures. In addition, the rising costs of health and social care and slow introduction of innovative solutions are a major frustration to policy-makers and care providers.

7 This is a critical time for Greater Manchester 20% The region s population is ageing: the over 65 population is expected to increase by 20% between 2011 and 2021, while the number of over 85s will rise by over 30%. Increase in over 65s population between 2011 and % Increase in over 85s population between 2011 and 2021 Significant lifestyle challenges: 17,000 deaths per year could be avoided through lifestyle changes. Over 110,000 people across GM are classed as long-term sick and inactive. High rates of ill health and mortality linked to mental health: poor mental health makes physical illness worse and raises total healthcare costs by at least 45% for each person with a long-term condition. Mental health problems cause at least 15,000 excess deaths per year. Greater Manchester challenge 2b Funding deficit to the economy by 2021 if no action is taken In addition, our region has some of the most severe and enduring health inequalities in the country and also experiences extreme variation across the region impacting on the quality and length of life.

8 Health Innovation Manchester is transforming and differentiating the region by: Positioning Greater Manchester as an internationally renowned location for life science, med-tech and digital healthcare research and innovation Accelerating the discovery, development and deployment of innovation that improves our population s health and wellbeing Contributing to national and international health and life science policy.

9 Three major opportunities The future of healthcare and medicine will be driven by exciting advances in basic research, particularly in genomics, digital technologies, and the development of health data analytics, using integrated big data sets which give us exceptional insight into entire citizen-level health pathways, and the ability to evaluate treatments and care pathways which can radically improve the prediction, prevention, and treatment of disease, and provide citizens with greater control over their own health and care. Greater Manchester s academic assets include internationally renowned work in genomics and in informatics; through Health Innovation Manchester these assets are also now aligned to the priority health needs of our 2.8m population, and to the work of industry partners, shortening the journey from discovery to the deployment of innovations which benefit our citizens directly. This work has already led to the world s first randomised real world drugs trial with GSK - the Salford Lung Study - and to the roll-out of informatics infrastructure which joins up the health records of Greater Manchester s entire population. between successful trial and adoption at pace and scale. Our innovation pathway has been developed with input and insight from the ABPI, responding to industry feedback about the need for a simple one-stop shop system for prioritising and evaluating innovations. Other such strategic partnerships are planned New business models will enable us to tackle the perverse incentives in existing health and care funding which inhibit investment. Devolution allows us to evaluate the costs and benefits of innovations across the whole care pathway, outside of individual institutional boundaries, and to develop funding models which incentivise providers to invest in innovation which creates patient and cost benefits in other parts of the system, but does not offer a direct return on investment to their own organisation. We believe strongly in the power of shared learning, and will work closely with partners in other cities and states, including the UK s Academic Health Science Networks, the Northern Health Science Alliance, and innovation hubs across the world. The opportunity A new approach to working with industry, focused on partnerships. We have the streamlined and accelerated decision-making structures which will tackle the challenges faced by industry in navigating disjointed systems. We have signed a partnership agreement with the Association of British Pharmaceutical Industries (ABPI) and are working closely with them to bring forward a pipeline of innovations which can rapidly be adopted across the whole Greater Manchester system, giving confidence to industry that we have bridged the gap

10 Greater Manchester s Innovation pathway Health Innovation Manchester is actively targeting innovations that span the health and social care spectrum; both those that require trialling, or have already been trialled and require system-wide adoption. A systematic approach to capturing, developing and prioritising innovations into a balanced portfolio. Through structured assessment and implementation planning processes, Health Innovation Manchester will manage the journey of these innovations, deploying them into the health and social care system as rapidly and effectively as possible. By applying sophisticated evaluation and assessment techniques, lessons can be learned for the future and improvements can be made quickly and efficiently. Proposed innovations Innovation Inflow & Screening Assessment against shared priorities for innovation with agreed criteria for evaluating and adopting proposals. Active horizon scanning of innovations, targeted calls to industry and industry engagement to identify prioritised innovations. Qualification & Impact Assessment Assessment of the feasibility and value of the proposal to the relevant parts of the health and care system.

11 Improved patient outcomes Achieving the greatest and fastest possible improvement to the health and wellbeing of the 2.8 million people living in our region and beyond. Implementation, Adoption & spread Evaluation Lessons learned Approach to innovation Clear and assured route from pilot to adoption across all relevant providers, benefiting from our extensive experience in delivering service change. Adopted ideas evaluated both quantitatively and qualitatively to measure benefits against expectations. A collective memory of lessons learned through the innovation pathway. Converting lessons learnt into evolving practice to ensure enduring improvements.

12 d Our capabilities: Clinical research excellence Through leveraging the existing internationally renowned clinical assets within Greater Manchester, Health Innovation Manchester is creating an end-to-end service, shortening the total time required to develop innovations and reach the market. This includes creating a onestop-shop for interested parties to access both translational and clinical pathways, a GM Research Hub that supports research initiation and delivery, an enhanced GM Clinical Trials Unit (CTU) and streamlined sponsorship arrangements that support the next generation of clinical research. Additionally, GM s significant and varied health challenges provide a large, diverse and reliable source of data and patients for clinical research trials. By aligning clinical trials with GM s health priorities, we have created an attractive location for industry innovators, leading to more commercial trials in the region and positioning Greater Manchester as a global hub for healthcare innovation. Why Health Innovation Manchester? A single access point for all clinical research and clinical trial queries, design and management via the GM Research Hub. Enhanced CTU to support the next generation of clinical trials (including real-world trials) that are more responsive to the demands of the private sector. This will include implementation of a more effective database to protect the safety of patients and enhance the pace of delivery. Enhanced infrastructure supporting sponsorship of highly complex, regulated clinical trials across GM. Accelerating the innovation pathway for medicines and health interventions, facilitating the quick diffusion of trials and delivering pharmaceuticals, devices and diagnostics to market.

13 Our capabilities: World class informatics infrastructure A unique strength in GM, where we have an internationally leading position especially in the integration of data and in the use of real-world evidence that can drive, policy, research and delivery of care. Our health informatics infrastructure leads the way in unlocking the value of integrated health data systems across GM s 2.8m population. Access to technologists, data scientists and clinicians all innovating together with one purpose - to identify cutting edge solutions that tackle health and care s biggest challenges - makes Greater Manchester an ideal location for the accelerated discovery, development, and deployment of innovation across the health and social care spectrum. Why Health Innovation Manchester? Datawell: the Datawell exchange platform has facilitated the ability of differing platforms and systems used across GM to allow the integration, sharing and safeguarding of data. FARSITE tool: primary care population stratification, feasibility and recruitment into trials or new care pathways. Connected Health Cities: across the North of England to aggregate data from a variety of sources and stakeholders - helping to implement improvements within specific pathways. Why Health Innovation Manchester We have already experienced the benefits of integrated data systems at locality level in attracting industry to innovate here. Our robust data infrastructure system enables us to attract research and innovation at scale and pace, and support the rapid assessment and evaluation of healthcare innovations.

14 Our capabilities: Precision medicine expertise Precision medicine links evidencebased research and innovation to diagnosis, care and treatments which are proactive, agile and bespoke to the individual, moving away from inefficient and ineffective patient management which is reactive and one size fits all Greater Manchester is exceptionally well-placed to lead innovation in precision medicine because of its high level of activity in biomarker discovery, validation, clinical trials, health economics and health informatics. Assets include the UK centre for the Medicines Discovery Catapult, the Stoller Biomarker Institute, and the NIHR Manchester, Biomedical Research Centre, focused on the application of the principles of precision medicine to a range of diseases which are prevalent within the GM population. allowing for rapid translation of scientific breakthroughs to become life-saving treatments delivered to patients. Why Health Innovation Manchester? Early identification, prevention and proactive management of disease. Precise diagnosis by greater understanding of the underlying aetiology instead of on presenting symptoms. Targeted interventions and improved patient experience - more accurate treatment strategies that apply bespoke stratification of patients, based on their individual characteristics. As part of Health Innovation Manchester these are integrated within the Greater Manchester Health and Social Care Partnership

15 Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing We will be brilliant communicators, excellent listeners, and good partners. We will ensure that industry understand the priorities and needs of our health and social care providers, and we will focus our efforts to meeting those needs. We will simplify and streamline access to the system for industry, and maintain regular dialogue with all stakeholders. We will promote our success, ensure our performance, and seek feedback on what we are doing well, and the distance still to travel. Above all, we will take advantage of the wonderful opportunity which devolution in Greater Manchester affords us, supporting the work of colleagues across GM health and social care for the benefit of our 2.8m population.

16 Discover Focusing our research excellence on local health priorities to exploit ground-breaking and leading-edge discovery for the benefit of citizens Develop Connecting academia, industry and healthcare providers to accelerate the development and evaluation of treatment and services Deploy Using Greater Manchester s integrated health and care system to create pathways that allow adoption of new technologies and treatments at pace Health Innovation Manchester Suite C, 3rd Floor, Citylabs, Nelson Street, Manchester M13

GREATER MANCHESTER HEALTH AND SOCIAL CARE STRATEGIC PARTNERSHIP BOARD

GREATER MANCHESTER HEALTH AND SOCIAL CARE STRATEGIC PARTNERSHIP BOARD GREATER MANCHESTER HEALTH AND SOCIAL CARE STRATEGIC PARTNERSHIP BOARD Date: 31 March 2017 6 Subject: Report of: Health Innovation Manchester Report Rowena Burns, Chief Executive, Manchester Science Partnerships

More information

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation Doing, supporting and using public health research The Public Health England strategy for research, development and innovation Draft - for consultation only About Public Health England Public Health England

More information

Technology and Innovation in the NHS Highlands and Islands Enterprise

Technology and Innovation in the NHS Highlands and Islands Enterprise Technology and Innovation in the NHS Highlands and Islands Enterprise Introduction Highlands and Islands Enterprise (HIE) welcomes the opportunity to respond to the Committee s call for views. We recognise

More information

Innovation & health connected. Business plan summary

Innovation & health connected. Business plan summary Innovation & health connected Business plan summary 2017-18 CONTENTS Contents Introduction What do we do? Our five goals Goal 1: Transformation through innovation Goal 2: Economic growth Goal 3: Adoption

More information

Higher Education Contribution to Health Science Innovation

Higher Education Contribution to Health Science Innovation Scottish University of the Year 2017 Higher Education Contribution to Health Science Innovation Professor Sir Pete Downes Principal, University of Dundee Lead Member for Health, Universities Scotland 28

More information

NHS Next Stage Review: Innovation

NHS Next Stage Review: Innovation NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused

More information

Priorities for medical research in the UK

Priorities for medical research in the UK Priorities for medical research in the UK Sir Leszek Borysiewicz Medical Research Council The Foundation for Science and Technology, 20 May 2009 MRC mission Encourage and support high-quality research

More information

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

Health Innovations in Horizon 2020: the framework programme for research and innovation ( ) Health Innovations in Horizon 2020: the framework programme for research and innovation (2014-2020) Virginija Dambrauskaite, MD, PhD Scientific Officer, Medical Research Unit, Health Directorate Directorate-General

More information

Our digital future. SEPA online. Facilitating effective engagement. Enabling business excellence. Sharing environmental information

Our digital future. SEPA online. Facilitating effective engagement. Enabling business excellence. Sharing environmental information Our digital future SEPA online Facilitating effective engagement Sharing environmental information Enabling business excellence Foreword Dr David Pirie Executive Director Digital technologies are changing

More information

FDA Centers of Excellence in Regulatory and Information Sciences

FDA Centers of Excellence in Regulatory and Information Sciences FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in

More information

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The

More information

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Technology and Innovation in the NHS Scottish Health Innovations Ltd Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop

More information

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif Connect and Catalyse Medicines and Healthcare the Global perspective (+10 years) Zahid Latif % GDP spent on health OECD countries spent nearly $3.5trn in 2005 ($4.6 trillion in 2008) on healthcare services

More information

Innovation for Defence Excellence and Security (IDEaS)

Innovation for Defence Excellence and Security (IDEaS) ASSISTANT DEPUTY MINISTER (SCIENCE AND TECHNOLOGY) Innovation for Defence Excellence and Security (IDEaS) Department of National Defence November 2017 Innovative technology, knowledge, and problem solving

More information

Response to the Western Australian Government Sustainable Health Review

Response to the Western Australian Government Sustainable Health Review Response to the Western Australian Government Sustainable Health Review On behalf of Australia s digital health community, HISA commends this submission to the Sustainable Health Review Panel, and wish

More information

Engaging UK Climate Service Providers a series of workshops in November 2014

Engaging UK Climate Service Providers a series of workshops in November 2014 Engaging UK Climate Service Providers a series of workshops in November 2014 Belfast, London, Edinburgh and Cardiff Four workshops were held during November 2014 to engage organisations (providers, purveyors

More information

Corporate slide master

Corporate slide master Corporate slide master Recommendations on Health & Wealth in Wales Ifan Evans Deputy Director Healthcare Innovation Welsh Government 1 What are these recommendations for? The Board s purpose is to: assist

More information

Welcome to the future of energy

Welcome to the future of energy Welcome to the future of energy Sustainable Innovation Jobs The Energy Systems Catapult - why now? Our energy system is radically changing. The challenges of decarbonisation, an ageing infrastructure and

More information

CCG 360 o stakeholder survey 2017/18

CCG 360 o stakeholder survey 2017/18 CCG 360 o stakeholder survey 2017/18 Case studies of high performing and improved CCGs 1 Contents 1 Background and key themes 2 3 4 5 6 East and North Hertfordshire CCG: Building on a strong internal foundation

More information

December Eucomed HTA Position Paper UK support from ABHI

December Eucomed HTA Position Paper UK support from ABHI December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing

More information

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018 HDR UK & Digital Innovation Hubs Introduction 22 nd November 2018 Health Data Research UK s vision To create a thriving, high-energy UK-wide network of inter-disciplinary research expertise that will:

More information

SMART PLACES WHAT. WHY. HOW.

SMART PLACES WHAT. WHY. HOW. SMART PLACES WHAT. WHY. HOW. @adambeckurban @smartcitiesanz We envision a world where digital technology, data, and intelligent design have been harnessed to create smart, sustainable cities with highquality

More information

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO Brief to the Senate Standing Committee on Social Affairs, Science and Technology Dr. Eliot A. Phillipson President and CEO June 14, 2010 Table of Contents Role of the Canada Foundation for Innovation (CFI)...1

More information

Executive Summary Industry s Responsibility in Promoting Responsible Development and Use:

Executive Summary Industry s Responsibility in Promoting Responsible Development and Use: Executive Summary Artificial Intelligence (AI) is a suite of technologies capable of learning, reasoning, adapting, and performing tasks in ways inspired by the human mind. With access to data and the

More information

Manchester: Driving Research and Innovation Through Partnerships

Manchester: Driving Research and Innovation Through Partnerships Manchester: Driving Research and Innovation Through Partnerships Manchester UK, has a wealth of world class research and innovation assets and is the country s first fully devolved health and social care

More information

Medicines Manufacturing in the UK 2017

Medicines Manufacturing in the UK 2017 Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership

More information

Imagine your future lab. Designed using Virtual Reality and Computer Simulation

Imagine your future lab. Designed using Virtual Reality and Computer Simulation Imagine your future lab Designed using Virtual Reality and Computer Simulation Bio At Roche Healthcare Consulting our talented professionals are committed to optimising patient care. Our diverse range

More information

FUTURE NOW Securing Digital Success

FUTURE NOW Securing Digital Success FUTURE NOW Securing Digital Success 2015-2020 Information Technology and Digital Services are vital enablers of the Securing Success Strategy 1 PREAMBLE The future has never been so close, or as enticing

More information

A Science & Innovation Audit for the West Midlands

A Science & Innovation Audit for the West Midlands A Science & Innovation Audit for the West Midlands June 2017 Summary Report Key Findings and Moving Forward 1. Key findings and moving forward 1.1 As the single largest functional economic area in England

More information

Implementation of Systems Medicine across Europe

Implementation of Systems Medicine across Europe THE CASyM ROADMAP Implementation of Systems Medicine across Europe A short roadmap guide 0 The road toward Systems Medicine A new paradigm for medical research and practice There has been a data generation

More information

Funding New Innovations

Funding New Innovations Funding New Innovations Dr Belinda Clarke Lead Technologist, Biosciences (Synthetic Biology) email: belinda.clarke@tsb.gov.uk twitter: @Belinda_Clarke What is the problem we are addressing? Business investment

More information

Digital Health and Introducing Innovative Technologies in the NHS

Digital Health and Introducing Innovative Technologies in the NHS Digital Health and Introducing Innovative Technologies in the NHS 22 September 2015 NATIONAL INFORMATION BOARD techuk.org @techuk #techuk Digital Health and introducing innovative technologies in the NHS

More information

The UK Prevention Research Partnership (UKPRP): Vision, objectives and rationale

The UK Prevention Research Partnership (UKPRP): Vision, objectives and rationale 1 The UK Prevention Research Partnership (UKPRP): Vision, objectives and rationale This document sets out the vision and objectives for the UKPRP. It includes outline information on the research funding

More information

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver Digital Health Jiban Khuntia, PhD Assistant Professor Business School University of Colorado Denver Digital Digital usually refers to something using digits, particularly binary digits. Examples: Digital

More information

Catapult Network. Launching your ideas with the UK s new centres for innovation

Catapult Network. Launching your ideas with the UK s new centres for innovation Catapult Network Launching your ideas with the UK s new centres for innovation The vision What is a Catapult? Hundreds of thousands of businesses in the UK are hungry for growth and capable of bringing

More information

BEING A PILOT CITY FOR 5G WILL HELP LEEDS BE THE BEST PLACE IT CAN BE TO LIVE, WORK AND PLAY WHY 5G IN LEEDS?

BEING A PILOT CITY FOR 5G WILL HELP LEEDS BE THE BEST PLACE IT CAN BE TO LIVE, WORK AND PLAY WHY 5G IN LEEDS? WHY 5G IN LEEDS? BEING A PILOT CITY FOR 5G WILL HELP LEEDS BE THE BEST PLACE IT CAN BE TO LIVE, WORK AND PLAY 2 WHY 5G IN LEEDS? INTRODUCTION 5G technologies offer Leeds the perfect opportunity to open

More information

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as: HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually

More information

Helping your business grow in the UK health system

Helping your business grow in the UK health system Helping your business grow in the UK health system OVERVIEW PROVIDING INSIGHT AND HELPING YOU DELIVER INNOVATIVE PRODUCTS AND SERVICES TO THE NHS AND BEYOND. The health system is a complex and uncertain

More information

The Citizen View of Government Digital Transformation 2017 Findings

The Citizen View of Government Digital Transformation 2017 Findings WHITE PAPER The Citizen View of Government Digital Transformation 2017 Findings Delivering Transformation. Together. Shining a light on digital public services Digital technologies are fundamentally changing

More information

WHY ACCOUNTANCY & SOCIAL DESIGN

WHY ACCOUNTANCY & SOCIAL DESIGN OPEN DESIGN STUDIO WHY ACCOUNTANCY & SOCIAL DESIGN Last year, we launched a ground-breaking partnership with the Royal Society of Art, which explored the future of our society and outlined a vision for

More information

The digital journey 2025 and beyond

The digital journey 2025 and beyond The digital journey 2025 and beyond The digital effect We are all, both personally and professionally, increasingly relying on digital services. As consumers, we are benefiting in many different aspects

More information

Catapult Network Summary

Catapult Network Summary Catapult Network Summary 2017 TURNING RESEARCH AND INNOVATION INTO GROWTH Economic impact through turning opportunities into real-world applications The UK s Catapults harness world-class strengths in

More information

Climate Change Innovation and Technology Framework 2017

Climate Change Innovation and Technology Framework 2017 Climate Change Innovation and Technology Framework 2017 Advancing Alberta s environmental performance and diversification through investments in innovation and technology Table of Contents 2 Message from

More information

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence ICDPPC declaration on ethics and data protection in artificial intelligence AmCham EU speaks for American companies committed to Europe on trade, investment and competitiveness issues. It aims to ensure

More information

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation Funding Position of the European Brain Council (EBC) Introduction The European Brain

More information

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints

More information

November 18, 2011 MEASURES TO IMPROVE THE OPERATIONS OF THE CLIMATE INVESTMENT FUNDS

November 18, 2011 MEASURES TO IMPROVE THE OPERATIONS OF THE CLIMATE INVESTMENT FUNDS November 18, 2011 MEASURES TO IMPROVE THE OPERATIONS OF THE CLIMATE INVESTMENT FUNDS Note: At the joint meeting of the CTF and SCF Trust Fund Committees held on November 3, 2011, the meeting reviewed the

More information

Parkinson s World A transformational project by The Cure Parkinson s Trust

Parkinson s World A transformational project by The Cure Parkinson s Trust Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication

More information

Why, How & What Digital Workplace

Why, How & What Digital Workplace Why, How & What Digital Workplace The Digital Workplace is the freedom to work as individuals and teams Anytime, Anyway, Anywhere Why commit to Digital Workplace transformation? Your digital workplace

More information

Industrial Strategy Green Paper Response from The Institute of Cancer Research, London

Industrial Strategy Green Paper Response from The Institute of Cancer Research, London Industrial Strategy Green Paper Response from The Institute of Cancer Research, London March 2017 The Institute of Cancer Research (ICR) is one of the world s most influential cancer research organisations

More information

ADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020

ADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020 ADVANCING KNOWLEDGE FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020 Social sciences and humanities research addresses critical

More information

2. Evidence themes and their importance along the development path

2. Evidence themes and their importance along the development path 1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development

More information

The new deal of data in the data-driven person centric-care

The new deal of data in the data-driven person centric-care The new deal of data in the data-driven person centric-care Maritta Perälä-Heape, Professor of practice, University of Oulu, Faculty of Medicine, Center for health and technology, Oulu, Finland OuluHealth

More information

DIGITAL WITH PLYMOUTH UNIVERSITY DIGITAL STRATEGY

DIGITAL WITH PLYMOUTH UNIVERSITY DIGITAL STRATEGY DIGITAL DIGITAL Vision Our vision is to ensure our world-class teaching, learning and research continues to thrive in an increasingly digital world by rapidly adapting to digital trends and exploiting

More information

TRIUMF ACCELERATING CANADIAN BUSINESS THROUGH SCIENCE AND INNOVATION Pre-Budget Consultation

TRIUMF ACCELERATING CANADIAN BUSINESS THROUGH SCIENCE AND INNOVATION Pre-Budget Consultation Canada s national laboratory for particle and nuclear physics Laboratoire national canadien pour la recherche en physique nucléaire et en physique des particules TRIUMF ACCELERATING CANADIAN BUSINESS THROUGH

More information

Translational scientist competency profile

Translational scientist competency profile C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective

More information

Information & Communication Technology Strategy

Information & Communication Technology Strategy Information & Communication Technology Strategy 2012-18 Information & Communication Technology (ICT) 2 Our Vision To provide a contemporary and integrated technological environment, which sustains and

More information

Health & Social Care Industrial Innovation

Health & Social Care Industrial Innovation Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging

More information

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is

More information

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA Pan-Canadian Vision and Strategy for Health Services and Policy Research 2014 2019 EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA Partners involved Alberta Cancer

More information

Conclusions on the future of information and communication technologies research, innovation and infrastructures

Conclusions on the future of information and communication technologies research, innovation and infrastructures COUNCIL OF THE EUROPEAN UNION Conclusions on the future of information and communication technologies research, innovation and infrastructures 2982nd COMPETITIVESS (Internal market, Industry and Research)

More information

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

25 th Workshop of the EURORDIS Round Table of Companies (ERTC) 25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00

More information

Before I talk through the strategy itself, I want to tell you more about why

Before I talk through the strategy itself, I want to tell you more about why This presentation was given by Dr Annette Bramley, the Healthcare Technologies Theme leader. She thanked Professor Nelson and Professor Taylor for their presentations, and thanked everyone at the meeting

More information

ABHI Response to the Kennedy short study on Valuing Innovation

ABHI Response to the Kennedy short study on Valuing Innovation ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.

More information

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and

More information

Future City Glasgow. City of Glasgow

Future City Glasgow. City of Glasgow Future City Glasgow Scottish Government City Council Universities Commercial Collaboration City of Glasgow Population 600,000/1.2Million Largest City in Scotland (4th UK) One Unitary Local Authority 5

More information

EU s Innovative Medical Technology and EMA s Measures

EU s Innovative Medical Technology and EMA s Measures EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency

More information

Digital Medical Device Innovation: A Prescription for Business and IT Success

Digital Medical Device Innovation: A Prescription for Business and IT Success 10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing

More information

SCIROCCO - Scaling Integrated Care in Context

SCIROCCO - Scaling Integrated Care in Context SCIROCCO - Scaling Integrated Care in Context Dr Andrea Pavlickova European Service Development Manager, NHS 24 ICIC 2016 23 May 2016, Barcelona SCIROCCO builds on the achievements of the European Innovation

More information

Making lives better every day. This is UCB

Making lives better every day. This is UCB Making lives better every day. This is UCB Kristof, living with axial spondyloarthritis Remi, UCB Inspired by patients. Driven by science. We have a shared ambition to transform the lives of people living

More information

Co-Design. Dr Louise Moody Coventry University Devices 4 Dignity, UK

Co-Design. Dr Louise Moody Coventry University Devices 4 Dignity, UK Co-Design Dr Louise Moody Coventry University Devices 4 Dignity, UK What is Devices 4 Dignity? D4D was set up in 2008 as one of two pilot Department of Health, Health Technology Cooperatives (HTCs) Funded

More information

TOURISM INSIGHT FRAMEWORK GENERATING KNOWLEDGE TO SUPPORT SUSTAINABLE TOURISM. IMAGE CREDIT: Miles Holden

TOURISM INSIGHT FRAMEWORK GENERATING KNOWLEDGE TO SUPPORT SUSTAINABLE TOURISM. IMAGE CREDIT: Miles Holden TOURISM INSIGHT FRAMEWORK GENERATING KNOWLEDGE TO SUPPORT SUSTAINABLE TOURISM IMAGE CREDIT: Miles Holden Prioritise insight to generate knowledge Insight is the lifeblood of the New Zealand tourism industry.

More information

Is housing really ready to go digital? A manifesto for change

Is housing really ready to go digital? A manifesto for change Is housing really ready to go digital? A manifesto for change December 2016 The UK housing sector is stuck in a technology rut. Ubiquitous connectivity, machine learning and automation are transforming

More information

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Rosmin Esmail MSc, CHE Director, Knowledge Translation Research, Analytics and Innovation Portfolio Alberta

More information

Cisco Live Healthcare Innovation Roundtable Discussion. Brendan Lovelock: Cisco Brad Davies: Vector Consulting

Cisco Live Healthcare Innovation Roundtable Discussion. Brendan Lovelock: Cisco Brad Davies: Vector Consulting Cisco Live 2017 Healthcare Innovation Roundtable Discussion Brendan Lovelock: Cisco Brad Davies: Vector Consulting Health Innovation Session: Cisco Live 2017 THE HEADLINES Healthcare is increasingly challenged

More information

Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive

Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive Opportunities and Challenges in Pharmaceutical Sciences Helen Gordon Chief Executive Challenges we face Drivers for Change in Health Care... and science too Desire for high quality, safe services. The

More information

CCG 360 o Stakeholder Survey

CCG 360 o Stakeholder Survey July 2017 CCG 360 o Stakeholder Survey National report NHS England Publications Gateway Reference: 06878 Ipsos 16-072895-01 Version 1 Internal Use Only MORI This Terms work was and carried Conditions out

More information

Managing Projects, Managing Knowledge

Managing Projects, Managing Knowledge Managing Projects, Managing Knowledge Loughborough University, KM Module 2017 Energy Technologies Institute LLP The information in this document is the property of Energy Technologies Institute LLP and

More information

MRC Health and Biomedical Informatics Research Strategy

MRC Health and Biomedical Informatics Research Strategy MRC Health and Biomedical Informatics Research Strategy NHS-HE Forum 25th May 2016 Rhoswyn Walker Head of Informatics Research Medical Research in the Big Data Era Vast amount of biomedical and population

More information

Cheshire, Warrington and Wirral Area Team Commissioning for Value Pack

Cheshire, Warrington and Wirral Area Team Commissioning for Value Pack Cheshire, Warrington and Wirral Area Team Commissioning for Value Pack February 2014 NHS England Gateway ref: 00525 1 Contents Context 3 Introduction: The call to action.... 4 The approach Where to look

More information

Regulatory Science and Innovation: FDA s Role in Transformation of the MCM Enterprise

Regulatory Science and Innovation: FDA s Role in Transformation of the MCM Enterprise Regulatory Science and Innovation: FDA s Role in Transformation of the MCM Enterprise Jesse L. Goodman, MD, MPH Chief Scientist and Deputy Commissioner for Science and Public Health (Acting), presentation

More information

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry

More information

DIGITAL TRANSFORMATION LESSONS LEARNED FROM EARLY INITIATIVES

DIGITAL TRANSFORMATION LESSONS LEARNED FROM EARLY INITIATIVES DIGITAL TRANSFORMATION LESSONS LEARNED FROM EARLY INITIATIVES Produced by Sponsored by JUNE 2016 Contents Introduction.... 3 Key findings.... 4 1 Broad diversity of current projects and maturity levels

More information

RESEARCH AND INNOVATION STRATEGY

RESEARCH AND INNOVATION STRATEGY RESEARCH AND INNOVATION STRATEGY 2015 2020 WELCOME Delivering new opportunities through globally significant research and innovation excellence The Research and Innovation Strategy is the result of significant

More information

THEFUTURERAILWAY THE INDUSTRY S RAIL TECHNICAL STRATEGY 2012 INNOVATION

THEFUTURERAILWAY THE INDUSTRY S RAIL TECHNICAL STRATEGY 2012 INNOVATION 73 INNOVATION 74 VISION A dynamic industry that innovates to evolve, grow and attract the best entrepreneurial talent OBJECTIVES Innovation makes a significant and continuing contribution to rail business

More information

Science and engineering driving the global economy David Delpy, CEO May 2012

Science and engineering driving the global economy David Delpy, CEO May 2012 ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL Science and engineering driving the global economy David Delpy, CEO May 2012 A CHANGING LANDSCAPE ROYAL CHARTER - 2003 (replacing Founding Charter of

More information

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on

More information

TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19

TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19 TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19 April 2018 Introduction 1. The TEC Board agreed four Strategic Priorities in August 2017 for furthering the development and

More information

A Field Guide to Exploring

A Field Guide to Exploring Empowered lives. Resilient nations. My Discover new approaches that UNDP and its partners are taking to achieve greater impact in complex environments. Empowered lives. Resilient nations. My UNDP BELIEVES

More information

Enabling ICT for. development

Enabling ICT for. development Enabling ICT for development Interview with Dr M-H Carolyn Nguyen, who explains why governments need to start thinking seriously about how to leverage ICT for their development goals, and why an appropriate

More information

STRATEGIC FRAMEWORK Updated August 2017

STRATEGIC FRAMEWORK Updated August 2017 STRATEGIC FRAMEWORK Updated August 2017 STRATEGIC FRAMEWORK The UC Davis Library is the academic hub of the University of California, Davis, and is ranked among the top academic research libraries in North

More information

PRIMARY CARE CO-COMMISSIONING

PRIMARY CARE CO-COMMISSIONING What is Co-Commissioning? Currently, hospital and community services are commissioned by CCGs, while primary care services are commissioned by NHSEngland, and Social Services by Local Authorities. NHSE

More information

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences

More information

NHS and Social Care Innovation and Diffusion Challenges

NHS and Social Care Innovation and Diffusion Challenges NHS and Social Care Innovation and Diffusion Challenges NHS and Social Care Innovation and Diffusion Challenges Produced by mhabitat Contents Foreword 4 Introduction 6 Section 1 Mapping support available

More information

Innovations in Health: Approaches from the Regional Innovation Funds

Innovations in Health: Approaches from the Regional Innovation Funds The Young Foundation March 2010 Innovations in Health: Approaches from the Regional Innovation Funds Geoff Mulgan, Young Foundation with the Regional Innovation Funds Advisory Service (RIFAS) team March

More information

TAB V. VISION 2030: Distinction, Access and Excellence

TAB V. VISION 2030: Distinction, Access and Excellence VISION 2030: Distinction, Access and Excellence PREAMBLE Oregon State University has engaged in strategic planning for nearly 15 years to guide how the university shall best serve the state, nation and

More information

EUROPEAN INNOVATION PARTNERSHIP FOR ACTIVE AND HEALTHY AGEING

EUROPEAN INNOVATION PARTNERSHIP FOR ACTIVE AND HEALTHY AGEING EUROPEAN INNOVATION PARTNERSHIP FOR ACTIVE AND HEALTHY AGEING Jorge Pinto Antunes Acting Head of Unit Innovation for Health and Consumers DG SANCO, European Commission 18 November 2014 Health in Europe

More information

Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization

Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings

More information

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry

More information

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017 A manifesto for global sustainable health Sustainable Health Symposium Cambridge, UK 25th July 2017 Introduction Across the globe, the health of individuals, their communities and the planet is in crisis

More information